Eupraxia Pharmaceuticals Inc. (EPRX)

USD 4.01

(3.76%)

Market Cap (In USD)

143.57 Million

Revenue (In USD)

-

Net Income (In USD)

-28.73 Million

Avg. Volume

16.46 Thousand

Currency
USD
Country
Healthcare
Open
-
Prev. Close
-
Day Range
-
Year Range
2.2-4.08
PE
-5.27
EPS
-0.76
Beta Value
1.228
ISIN
CA29842P1053
CUSIP
-
CIK
-
Shares
35849400.0
Earnings Annoncement
-

Company Profile

Sector
Healthcare
Industry
Biotechnology
CEO
Dr. James A. Helliwell FRCPC, M.D.
Employee Count
-
Website
-
Ipo Date
Details
-